StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc. (TMO) stock

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 10/3030% above fair value
$692.74+5.95 (+0.87%)

Close on Nov 18, 2026Market cap $256.67BP/E 36.6Yield 0.25%

Thermo Fisher Scientific free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Thermo Fisher Scientific's free cash flow for the twelve months ending Sep 26, 2026 was $7.60B, up 24.3% year over year. For fiscal 2025 it was $6.29B, down 13.4% from the year before. Over ten years it grew 9.6% a year on average. The highest annual figure on record is $7.27B in fiscal 2024.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.29B-13.4%
FY2024Dec 31, 2024$7.27B+4.9%
FY2023Dec 31, 2023$6.93B+0.2%
FY2022Dec 31, 2022$6.91B+1.8%
FY2021Dec 31, 2021$6.79B-0.4%
FY2020Dec 31, 2020$6.82B+68.4%
FY2019Dec 31, 2019$4.05B+6.9%
FY2018Dec 31, 2018$3.79B+8.2%
FY2017Dec 31, 2017$3.50B+24.3%
FY2016Dec 31, 2016$2.81B+11.7%
FY2015Dec 31, 2015$2.52B+14.9%
FY2014Dec 31, 2014$2.19B+26.8%
FY2013Dec 31, 2013$1.73B+0.2%
FY2012Dec 31, 2012$1.72B+20.6%
FY2011Dec 31, 2011$1.43B+14.2%
FY2010Dec 31, 2010$1.25B-14.2%
FY2009Dec 31, 2009$1.46B+26.3%
FY2008Dec 31, 2008$1.16B-11.6%
FY2007Dec 31, 2007$1.31B–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 26, 2026$2.11B+15.1%
Q2 FY2026Jun 27, 2026$1.68B+51.6%
Q1 FY2026Mar 28, 2026$816.00M+126.0%
Q4 FY2025Dec 31, 2025$2.99B+6.5%
Q3 FY2025Sep 27, 2025$1.84B-3.1%
Q2 FY2025Jun 28, 2025$1.11B-33.4%
Q1 FY2025Mar 29, 2025$361.00M-60.1%
Q4 FY2024Dec 31, 2024$2.81B-15.3%
Q3 FY2024Sep 28, 2024$1.89B-9.0%
Q2 FY2024Jun 29, 2024$1.66B+32.1%
Q1 FY2024Mar 30, 2024$904.00M+233.6%
Q4 FY2023Dec 31, 2023$3.32B+13.0%
Q3 FY2023Sep 30, 2023$2.08B+49.8%
Q2 FY2023Jul 1, 2023$1.26B+22.9%
Q1 FY2023Apr 1, 2023$271.00M-82.7%
Q4 FY2022Dec 31, 2022$2.94B+80.6%
Q3 FY2022Oct 1, 2022$1.39B-34.6%
Q2 FY2022Jul 2, 2022$1.02B-39.4%
Q1 FY2022Apr 2, 2022$1.56B+15.7%
Q4 FY2021Dec 31, 2021$1.63B-40.9%
Q3 FY2021Oct 2, 2021$2.13B-9.2%
Q2 FY2021Jul 3, 2021$1.69B+4.3%
Q1 FY2021Apr 3, 2021$1.35B+1210.7%
Q4 FY2020Dec 31, 2020$2.75B+69.5%
Q3 FY2020Sep 26, 2020$2.34B+159.9%
Q2 FY2020Jun 27, 2020$1.62B+50.6%
Q1 FY2020Mar 28, 2020$103.00M-77.0%
Q4 FY2019Dec 31, 2019$1.62B+7.1%
Q3 FY2019Sep 28, 2019$901.00M-13.9%
Q2 FY2019Jun 29, 2019$1.07B-14.8%
Q1 FY2019Mar 30, 2019$448.00M–
Q4 FY2018Dec 31, 2018$1.52B-8.1%
Q3 FY2018Sep 29, 2018$1.05B+28.2%
Q2 FY2018Jun 30, 2018$1.26B+65.7%
Q1 FY2018Mar 31, 2018-$40.00M-114.9%
Q4 FY2017Dec 31, 2017$1.65B+54.0%
Q3 FY2017Sep 30, 2017$817.00M–
Q2 FY2017Jul 1, 2017$761.00M–
Q1 FY2017Apr 1, 2017$268.00M–
Q4 FY2016Dec 31, 2016$1.07B–

More Thermo Fisher Scientific figures

See a number that looks wrong?